Cargando…

Jo-1 Antibodies From Myositis Induce Complement-Dependent Cytotoxicity and TREM-1 Upregulation in Muscle Endothelial Cells

BACKGROUND AND OBJECTIVES: Muscle microangiopathy due to dysfunction of endothelial cells because of inflammation is a critical hallmark of dermatomyositis (DM); however, its pathomechanism remains unclear. The aim of this study was to evaluate the effect of immunogloblin G (IgG) from patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Honda, Masaya, Shimizu, Fumitaka, Sato, Ryota, Mizukami, Yoichi, Watanabe, Kenji, Takeshita, Yukio, Maeda, Toshihiko, Koga, Michiaki, Kanda, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162704/
https://www.ncbi.nlm.nih.gov/pubmed/37147138
http://dx.doi.org/10.1212/NXI.0000000000200116
_version_ 1785037749858861056
author Honda, Masaya
Shimizu, Fumitaka
Sato, Ryota
Mizukami, Yoichi
Watanabe, Kenji
Takeshita, Yukio
Maeda, Toshihiko
Koga, Michiaki
Kanda, Takashi
author_facet Honda, Masaya
Shimizu, Fumitaka
Sato, Ryota
Mizukami, Yoichi
Watanabe, Kenji
Takeshita, Yukio
Maeda, Toshihiko
Koga, Michiaki
Kanda, Takashi
author_sort Honda, Masaya
collection PubMed
description BACKGROUND AND OBJECTIVES: Muscle microangiopathy due to dysfunction of endothelial cells because of inflammation is a critical hallmark of dermatomyositis (DM); however, its pathomechanism remains unclear. The aim of this study was to evaluate the effect of immunogloblin G (IgG) from patients with idiopathic inflammatory myopathies (IIM) on muscle endothelial cells in vitro. METHODS: Using a high-content imaging system, we analyzed whether IgG purified from sera from patients with IIM (n = 15), disease controls (DCs: n = 7), and healthy controls (HCs: n = 7) can bind to muscle endothelial cells and induce complement-dependent cellular cytotoxicity. RESULTS: IgGs from Jo-1 antibody myositis could bind to muscle endothelial cells and caused complement-dependent cell cytotoxicity. RNA-seq demonstrated the upregulation of genes associated with tumor necrosis factor (TNF)-α, triggering receptor expressed on myeloid cells-1 (TREM-1), CD25, and mitochondria pathways after exposure to IgG from the Jo-1, signal recognition particle (SRP), and polymyositis (PM) groups. The high-content imaging system showed that TREM-1 expression in the Jo-1, SRP, and PM groups was increased in comparison with DCs and HCs and that the TNF-α expression in the Jo-1 group was higher in comparison with the SRP, PM, DC, and HC groups. The expression of TREM-1 was observed in biopsied capillaries and the muscle membrane from patients with Jo-1 and in biopsied muscle fiber and capillaries from patients with DM and SRP. The depletion of Jo-1 antibodies by IgG of patients with Jo-1 antibody myositis reduced the Jo-1 antibody–induced complement-dependent cellular cytotoxicity in muscle endothelial cells. DISCUSSION: Jo-1 antibodies from Jo-1 antibody myositis show complement-dependent cellular cytotoxicity in muscle endothelial cells. IgGs from patients with Jo-1, SRP, and DM increase the TREM-1 expression in endothelial cells and muscles.
format Online
Article
Text
id pubmed-10162704
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101627042023-05-06 Jo-1 Antibodies From Myositis Induce Complement-Dependent Cytotoxicity and TREM-1 Upregulation in Muscle Endothelial Cells Honda, Masaya Shimizu, Fumitaka Sato, Ryota Mizukami, Yoichi Watanabe, Kenji Takeshita, Yukio Maeda, Toshihiko Koga, Michiaki Kanda, Takashi Neurol Neuroimmunol Neuroinflamm Research Article BACKGROUND AND OBJECTIVES: Muscle microangiopathy due to dysfunction of endothelial cells because of inflammation is a critical hallmark of dermatomyositis (DM); however, its pathomechanism remains unclear. The aim of this study was to evaluate the effect of immunogloblin G (IgG) from patients with idiopathic inflammatory myopathies (IIM) on muscle endothelial cells in vitro. METHODS: Using a high-content imaging system, we analyzed whether IgG purified from sera from patients with IIM (n = 15), disease controls (DCs: n = 7), and healthy controls (HCs: n = 7) can bind to muscle endothelial cells and induce complement-dependent cellular cytotoxicity. RESULTS: IgGs from Jo-1 antibody myositis could bind to muscle endothelial cells and caused complement-dependent cell cytotoxicity. RNA-seq demonstrated the upregulation of genes associated with tumor necrosis factor (TNF)-α, triggering receptor expressed on myeloid cells-1 (TREM-1), CD25, and mitochondria pathways after exposure to IgG from the Jo-1, signal recognition particle (SRP), and polymyositis (PM) groups. The high-content imaging system showed that TREM-1 expression in the Jo-1, SRP, and PM groups was increased in comparison with DCs and HCs and that the TNF-α expression in the Jo-1 group was higher in comparison with the SRP, PM, DC, and HC groups. The expression of TREM-1 was observed in biopsied capillaries and the muscle membrane from patients with Jo-1 and in biopsied muscle fiber and capillaries from patients with DM and SRP. The depletion of Jo-1 antibodies by IgG of patients with Jo-1 antibody myositis reduced the Jo-1 antibody–induced complement-dependent cellular cytotoxicity in muscle endothelial cells. DISCUSSION: Jo-1 antibodies from Jo-1 antibody myositis show complement-dependent cellular cytotoxicity in muscle endothelial cells. IgGs from patients with Jo-1, SRP, and DM increase the TREM-1 expression in endothelial cells and muscles. Lippincott Williams & Wilkins 2023-05-05 /pmc/articles/PMC10162704/ /pubmed/37147138 http://dx.doi.org/10.1212/NXI.0000000000200116 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Research Article
Honda, Masaya
Shimizu, Fumitaka
Sato, Ryota
Mizukami, Yoichi
Watanabe, Kenji
Takeshita, Yukio
Maeda, Toshihiko
Koga, Michiaki
Kanda, Takashi
Jo-1 Antibodies From Myositis Induce Complement-Dependent Cytotoxicity and TREM-1 Upregulation in Muscle Endothelial Cells
title Jo-1 Antibodies From Myositis Induce Complement-Dependent Cytotoxicity and TREM-1 Upregulation in Muscle Endothelial Cells
title_full Jo-1 Antibodies From Myositis Induce Complement-Dependent Cytotoxicity and TREM-1 Upregulation in Muscle Endothelial Cells
title_fullStr Jo-1 Antibodies From Myositis Induce Complement-Dependent Cytotoxicity and TREM-1 Upregulation in Muscle Endothelial Cells
title_full_unstemmed Jo-1 Antibodies From Myositis Induce Complement-Dependent Cytotoxicity and TREM-1 Upregulation in Muscle Endothelial Cells
title_short Jo-1 Antibodies From Myositis Induce Complement-Dependent Cytotoxicity and TREM-1 Upregulation in Muscle Endothelial Cells
title_sort jo-1 antibodies from myositis induce complement-dependent cytotoxicity and trem-1 upregulation in muscle endothelial cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162704/
https://www.ncbi.nlm.nih.gov/pubmed/37147138
http://dx.doi.org/10.1212/NXI.0000000000200116
work_keys_str_mv AT hondamasaya jo1antibodiesfrommyositisinducecomplementdependentcytotoxicityandtrem1upregulationinmuscleendothelialcells
AT shimizufumitaka jo1antibodiesfrommyositisinducecomplementdependentcytotoxicityandtrem1upregulationinmuscleendothelialcells
AT satoryota jo1antibodiesfrommyositisinducecomplementdependentcytotoxicityandtrem1upregulationinmuscleendothelialcells
AT mizukamiyoichi jo1antibodiesfrommyositisinducecomplementdependentcytotoxicityandtrem1upregulationinmuscleendothelialcells
AT watanabekenji jo1antibodiesfrommyositisinducecomplementdependentcytotoxicityandtrem1upregulationinmuscleendothelialcells
AT takeshitayukio jo1antibodiesfrommyositisinducecomplementdependentcytotoxicityandtrem1upregulationinmuscleendothelialcells
AT maedatoshihiko jo1antibodiesfrommyositisinducecomplementdependentcytotoxicityandtrem1upregulationinmuscleendothelialcells
AT kogamichiaki jo1antibodiesfrommyositisinducecomplementdependentcytotoxicityandtrem1upregulationinmuscleendothelialcells
AT kandatakashi jo1antibodiesfrommyositisinducecomplementdependentcytotoxicityandtrem1upregulationinmuscleendothelialcells